Fierce Healthcare December 17, 2019
Heather Landi

NYU Langone Health’s new biotech incubator will support the translation of game-changing discoveries by scientists into new treatments for patients.

NYU Langone Health opened a 50,000 square-foot biotech incubator space in Manhattan that backing from big-name corporate sponsors including biopharma giants Bristol-Myers Squibb, Sanofi, and Boehringer Ingelheim.

The health system’s biotech incubator is part of a larger effort by New York City and the state of New York improve the city’s standing as a top-tier biopharma hub after years of lagging behind Boston/Cambridge, MA, and the San Francisco Bay Area.

NYU Langone invested $8 million to renovate a building in the Hudson Square area of Manhattan to house laboratories and office space for early-stage biotechnology and life sciences startups.

“This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Pharma, Precision Medicine, Provider, Technology
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article